Lung tissue mitochondrial benzodiazepine receptors increase in a model of pulmonary inflammation

S H Audi1, C A Dawson, S B Ahlf

  • 1Biomedical Engineering Department, Marquette University, Milwaukee, WI 53201-1881, USA. audis@marquette.edu

Lung
|December 19, 2002
PubMed

Insights

Pulmonary inflammation increases lung uptake of diazepam. Mitochondrial benzodiazepine receptors (mBRs) are implicated, suggesting potential for mBR ligands in detecting lung inflammation.

Area of Science:

  • Pharmacology and Toxicology
  • Respiratory Medicine
  • Cell Biology

Background:

  • Pulmonary inflammation, induced by Complete Freund's Adjuvant (CFA), enhances lung uptake of 14C-diazepam.
  • Mitochondrial benzodiazepine receptors (mBRs) are implicated in various cellular processes, including inflammation.

Purpose of the Study:

  • To investigate the contribution of mitochondrial benzodiazepine receptors (mBRs) to increased lung uptake of diazepam during pulmonary inflammation.
  • To assess the density of mBRs and their correlation with inflammatory markers in an experimental model of lung inflammation.

Main Methods:

  • Isolated perfused rabbit lungs (normal and CFA-inflamed) were used to measure 14C-diazepam pulmonary venous effluent.
  • PK11195, an inhibitor of diazepam binding to mBRs, was administered to assess receptor involvement.
  • Lung tissue caspase-3 activity was measured as an indicator of inflammation.

Main Results:

  • Pulmonary inflammation significantly increased lung tissue mBR density.
  • An inverse correlation was observed between mBR density and lung tissue caspase-3 activity in inflamed lungs.
  • PK11195 partially inhibited diazepam uptake, confirming mBR involvement.

Conclusions:

  • Mitochondrial benzodiazepine receptors play a role in the increased lung uptake of diazepam during pulmonary inflammation.
  • Increased mBR density in inflamed lungs may be linked to the apoptotic elimination of inflammatory cells.
  • mBR ligands show potential for noninvasive detection and characterization of pulmonary inflammation using nuclear medicine.